Home » Topics » Regulatory » Patents

Patents
RSS

New GHS-R1a ligands claimed by GSK as a treatment option for obesity

Jan. 13, 2009

GSK divulges a series of ghrelin receptor ligands for the treatment of binge eating

Jan. 13, 2009

Recent Argenta Discovery patent discloses new HNE inhibitors for respiratory disorders

Jan. 12, 2009

Novartis imparts novel chemokine CXCR2 receptor antagonists in recent patent

Jan. 12, 2009

Astellas claims new N-type calcium channel blockers for alleviating pain

Jan. 12, 2009

Novel anti-EGFR family member antibodies described in recent patent

Jan. 12, 2009

Xenon discloses new sodium channel blockers with analgesic properties

Jan. 12, 2009

Janssen has synthesized novel DGAT-1 inhibitors with potental as antidiabetic agents

Jan. 9, 2009

Recent Argenta Discovery patent describes new HNE inhibitors for treatment of respiratory disorders

Jan. 9, 2009

New chemokine CXCR2 receptor antagonists disclosed in recent Novartis patent

Jan. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...